SCHEMBL7362147

SCHEMBL7362147

CCS(=O)(=O)NN=Cc1ccc(CN2CC(C3CCCCC3)C[C@H]2C(=O)NC(=O)[C@H](C)N)cc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7249630 0.88 NPC1 (0.30)
SCHEMBL7465555 0.80 MC3R (0.31)
SCHEMBL7104014 0.80 OPRM1 (0.37)
SCHEMBL7252651 0.80 NPSR1 (0.32)
Hydrochloric Acid SCHEMBL7156752 0.80 MC3R (0.31)
SCHEMBL7247787 0.79 F2 (0.35)
Hydrochloric Acid SCHEMBL7158175 0.78 F2 (0.36)
SCHEMBL7249203 0.76 MC3R (0.33)
Hydrochloric Acid SCHEMBL7160547 0.76 MC3R (0.33)
SCHEMBL7104093 0.76 NPSR1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010018423-A1 Anticoagulant agents KLIMKOWSKI VALENTINE J (US) 2001-08-30 US claimed
US-6200967-B1 USED AS THROMBIN INHIBITORS, COAGULATION INHIBITORS AND AGENTS FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS ELI LILLY AND COMPANY 2001-03-13 US claimed
WO-1997049404-A1 ANTICOAGULANT AGENTS ELI LILLY AND COMPANY (US) 1997-12-31 WO claimed